Some 3 million Americans suffer from celiac disease, a serious autoimmune disorder triggered by a reaction to gluten, mostly found in wheat products. For them, the search for gluten-free food has long meant joyless excursions to fern-filled health-food shops for comestibles that are often flavorless. Why, then, are so many people without the disease also devouring gluten-free foods? Many have done so out of perceived allergy concerns (gluten sensitivity is this decade’s lactose intolerance) or simply because it’s the diet buzzword du jour. Eager to cash in on that demand, mainstream manufacturers such as Campbell Soup (CPB) and General Mills (GIS) have helped create an industry estimated at $2.6 billion by SupermarketGuru. Now companies that had nothing to do with gluten are trying to slap “gluten-free” on their label. We’re talking about you, Star Vodka.

Sax is a Bloomberg Businessweek contributor and author of The Tastemakers: Why We're Crazy for Cupcakes but Fed Up with Fondue.

The Aging of Abercrombie & Fitch

Companies Mentioned

  • CPB
    (Campbell Soup Co)
    • $46.7 USD
    • -0.73
    • -1.56%
  • GIS
    (General Mills Inc)
    • $54.56 USD
    • -0.22
    • -0.4%
Market data is delayed at least 15 minutes.
blog comments powered by Disqus